D. Buonsenso1, S. Cristaldi1, A. Reale1, I. Tarissi de Jacobis2, L. Granata2 and A. Marchesi2.
1 Pediatric Emergency Department, Bambino Gesù Children's Hospital, Institute for Research and Health Care (IRCCS), Rome, Italy.
2
Pediatric and Infectious Disease Unit, Bambino Gesù Children's
Hospital, Institute for Research and Health Care (IRCCS), Rome, Italy.
Corresponding
author: Danilo Buonsenso, MD, Catholic University of Sacred Heart - A.
Gemelli Hospital, Department of Pediatrics, Pediatric Infectious
Disease Unit, Largo A. Gemelli 8, 00168 Rome, Italy. E-mail:
danilobuonsenso@gmail.com
Published: June 20, 2018
Received: February 28, 2018
Accepted: May 14, 2018
Mediterr J Hematol Infect Dis 2018, 10(1): e2018037 DOI
10.4084/MJHID.2018.037
This article is available on PDF format at:
This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0),
which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
|
Abstract
Kawasaki
disease (KD) is an acute, self-limited, inflammatory disease affecting
medium-sized arteries and particularly the coronary arteries in about
25% of untreated cases. KD is a clinical diagnosis based on the
presence of ≥5 days of fever and the presence of ≥4 of the 5 principal
clinical criteria. We described, for the first time to our knowledge, a
case of a very early development (on day 1) of typical KD with
transient coronary involvement, diagnosed on day 2 of disease and
treated with aspirin and steroids on day 3, with complete resolution of
clinical signs and coronary involvement.
|
Case
A
4-month-old, Italian, male infant came to our emergency department
because of fever since 24 hours and rash since 6 hours. A few hours
before our evaluation, the child had been evaluated by his family
doctor who suspected a urinary tract infection and prescribed urine
analyses. The child received the first immunization as for his age and
no drugs taken before the admission.
The child was suffering and
irritable, the physical examination revealed a polymorphous skin rash
involving mainly the genital area, feet and hands edema without palmar
skin rash, non-purulent bilateral conjunctive injection and important
cheilitis characterized with an intense lips redness and cracking.
Complete
blood count revealed White Blood Cell Count of 11,150/mmc (N 46%, L
34.3%), Platelets 291000/mmc, C-reactive protein was 5,78 mg/dL (normal
value < 0.5), Procalcitonine was within normal range for age, LDH
542 UI/l, fibrinogen 550 mg/dl.
Despite some clinical findings
were consistent with Kawasaki Disease (KD), the child presented fever
since only 24 hours, therefore blood and urine and liquor cultures were
taken and empiric broad-spectrum antibiotic therapy was started.
Urinalyses were normal with no pyuria, no esterase nor nitrites.
Cerebrospinal fluid chemical results were normal, no pleocytoss. The
next morning the child was admitted to the Pediatric and Infectious
Disease Unit of our Hospital. In the pediatric unit other common viral
infections were ruled out (herpes virus, Epstein-barr virus, coxsackie
virus, enterovirus, adenovirus, measles). 24 hours later (48 hours from
fever onset), due to the persistence of fever and clinical signs
suspicious for KD, echocardiogram was performed and mild dilatation of
the common trunk (26 mm, Z-score: 3) and the proximal tract of the
anterior descending left coronary artery (17 mm; Z-score 2.4)
documented. The right coronary artery was within normal ranges but
showed mild hyperecogenicity of the proximal tract.
Therefore,
although in third day of illness, treatment with intravenous
immunoglobulin at the standard dose of 2 g/kg in 12–18 hours and
metildprednisolone was started. Low-dose aspirin (5 mg/kg) was started
as well; the patient achieved a complete fever resolution in 24 hours.
On the fifth day of disease, echocardiogram was repeated and showed
stable findings. On the 12th day, a
new echocardiogram was performed and showed complete normalization of
coronary findings. The child was then discharged in good clinical
conditions with no signs or symptoms, with no problems to highlight a 2
months of follow-up.
Discussion
We
described the case of a young infant who developed in only 24 hours all
typical signs and symptoms of KD with coronary artery transitory
involvement.
Kawasaki disease is an acute, self-limited,
inflammatory disease of unknown etiology. It is associated with
vasculitis, mainly affecting medium-sized arteries and particularly the
coronary arteries in about 25% of untreated cases, being the most
common cause of acquired heart disease in children in developed
countries.[1-3]
KD is usually observed in children less than 5 years in over 80% of cases,[4] but there are described cases in neonates, teenagers, and even in adults.[5]
KD
is a clinical diagnosis based on the presence of ≥5 days of fever
(first calendar day of fever is illness day 1) and the presence of ≥4
of five principal clinical criteria (extremity changes, rash,
conjunctivitis, oral changes and cervical lymphadenopathy).[6]
In
presence of > 4 main clinical criteria and/or presence of coronary
arteries involvement, the diagnosis can be made within 4 days of fever.
Nevertheless, the clinical features are typically not all present at a
single point in time, and it is generally not possible to establish the
diagnosis very early in the course.[7] Similarly,
experienced clinicians who have treated many KD patients may make the
diagnosis in rare instances with only 3 days of fever in the presence
of a classic clinical presentation. Typically, the clinical features
are not all present at a single point in time, and it is generally not
possible to establish the diagnosis very early in the course.
Similarly, some clinical features may have abated in patients who
present after 1 to 2 weeks of fever, and a careful review of prior
signs and symptoms can help establish the diagnosis.[7]
Obviously,
to reach an early diagnosis or a late one when other signs or symptoms
disappeared, other diagnosis should be ruled out, including viral
infections.[8]
Unusually, our patient developed
all clinical signs of typical KD in only 24 hours and already at 36
hours from fever onset (day 2 of disease) developed coronary dilatation
(small aneurysms (Z Score ≥2.5 to <5) according to current
guidelines).[7]
The very early diagnosis allowed
the early treatment with IGIV and steroids, with rapid resolution of
fever and the requirement of addition therapy, and resolution of
coronary involvement within seven days.
Although corticosteroids
are the treatment of choice in other forms of vasculitis, their use has
been controversial for children with KD.[9] Patients
believed to be at high risk for development of coronary artery
aneurysms (as in our case since the child already developed small
aneurisms at 23 hours of disease) may benefit from primary adjunctive
therapy.[7] In particular, a recent study found that
an early coronary dilatation was independently associated with the
occurrence of progressive coronary dilatation and therefore in these
cases adjuvant therapies apart from immunoglobulin therapies may
benefit the outcome.[10]
A recent meta-analysis evaluated nineteen studies published between 1999 and 2016.[11]
There was a significant reduction in incidence of coronary artery
involvement with usage of corticosteroid with a pooled odds ratio of
0.72 (95% CI 0.57e0.92; p Z 0.01) than that without usage of
corticosteroid. In general, a greater effect was seen in the patient
received corticosteroid as initial and adjuvant therapy with
intravenous immune globulin (pooled odds ratio 0.39, 95% CI 0.21e0.73,
p Z 0.007) than those who received corticosteroid as rescue therapy.
Some
authors postulated that very young infant with incomplete KD might
experience an asymptomatic or pauci-symptomatic disease course
secondary to the presence of passively acquired maternal antibodies, in
the hypothesis that an unknown infectious agent[6,12] may trigger KD.
Despite
some published case reports support this hypothesis, our case seems to
contradict it since he rapidly developed all typical signs and symptoms
of KD with coronary involvement in less than 48 hours. To our
knowledge, this is the first described case with such a rapid
development and diagnosis of KD.
Conclusions
We
described, for the first time to our knowledge, a case of a very early
development of typical KD with transient coronary involvement,
highlighting the multiform potential clinical presentation of KD, a
syndrome better described as a clinical spectrum other than a classic
disease, due to its variability from standard disease to very severe or
even asymptomatic cases. This case may also help other clinicians to
support the diagnosis of KD in such a short time when typical signs and
symptoms are present, even with only 36-48 hours of fever.
References
- Kuo HC, Hsu YW, Wu MS, et al. Intravenous
immunoglobulin, pharmacogenomics, and Kawasaki disease. J. Microbiol.
Immunol. Infect. 2016;49:1e7 .
- Moffett
BS, Syblik D, Denfield S, et al. Epidemiology of immunoglobulin
resistant Kawasaki disease: results from a large, national database.
Pediatr. Cardiol. 2015;36:374e8. .
- Nakamura
Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki
disease in Japan: results of the 2009e2010 nationwide survey. J.
Epidemiol. 2012;22:216e21. .
- Kim
GB, Han JW, Park YW, et al. Epidemiologic features of Kawasaki disease
in South Korea: data from nationwide survey, 2009-2011. Pediatr.
Infect. Dis. J. 2014;33:24-7 https://doi.org/10.1097/INF.0000000000000010 PMid:24064559 .
- Falcini
F, Capannini S, Rigante D. Kawasaki syndrome: an intriguing disease
with numerous unsolved dilemmas. Pediatr. Rheumatol. 2011;9:17. https://doi.org/10.1186/1546-0096-9-17 PMid:21774801 PMCid:PMC3163180 .
- Newburger
JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term
management of Kawasaki disease: a statement for health professionals
from the Committee on Rheumatic Fever, Endocarditis and Kawasaki
Disease, Council on Cardiovascular Disease in the Young, American Heart
Association. Circulation. 2004;110:2747–2771. https://doi.org/10.1161/01.CIR.0000145143.19711.78 PMid:15505111 .
- McCrindle
BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term
Management of Kawasaki Disease: A Scientific Statement for Health
Professionals From the American Heart Association. Circulation.
2017;135:e927–e999 https://doi.org/10.1161/CIR.0000000000000484 PMid:28356445 .
- Rigante
D, Cantarini L, Piastra M, Angelone DF, Valentini P, Pardeo M,
Buonsenso D, Delogu AB, Serranti D, De Nisco A, Compagnone A, De Rosa
G. Kawasaki syndrome and concurrent Coxsackie virus B3 infection.
Rheumatol Int. 2012 Dec;32(12):4037-40. https://doi.org/10.1007/s00296-010-1613-0 PMid:21052673 .
- Shulman ST. Is there a role for corticosteroids in Kawasaki disease? J. Pediatr. 2003;142:601–603. https://doi.org/10.1067/mpd.2003.258 PMid:12838185 .
- Liu
MY, Liu HM, Wu CH, et al. Risk factors and implications of progressive
coronary dilatation in children with Kawasaki disease. BMC Pediatr.
2017 Jun 6;17(1):139. https://doi.org/10.1186/s12887-017-0895-8 PMid:28587647 PMCid:PMC5461724 .
- Yang
TJ, Lin MT, Lu CY, et al. The prevention of coronary arterial
abnormalities in Kawasaki disease: A meta-analysis of the
corticosteroid effectiveness. J. Microbiol. Immunol. Infect.
2017;S1684-1182(17)30195-0 ..
- Pinches
H, Dobbins K, Cantrell S, et al. Asymptomatic Kawasaki Disease in a
3-Month-Old Infant. Pediatrics. 2016;138(2):e20153936 https://doi.org/10.1542/peds.2015-3936 PMid:27371760 .
[TOP]